Residual inflammatory risk in coronary heart disease: incidence of elevated high-sensitive CRP in a real-world cohort

BACKGROUND: Inflammation drives atherosclerosis and its complications. Anti-inflammatory therapy with interleukin 1 beta (IL-1β) antibody reduces cardiovascular events in patients with elevated high-sensitive C-reactive protein (hsCRP). This study aims to identify the share of patients with coronary...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Res Cardiol
Main Authors: Peikert, Alexander, Kaier, Klaus, Merz, Julian, Manhart, Lucas, Schäfer, Ibrahim, Hilgendorf, Ingo, Hehn, Philipp, Wolf, Dennis, Willecke, Florian, Sheng, Xia, Clemens, Andreas, Zehender, Manfred, von zur Mühlen, Constantin, Bode, Christoph, Zirlik, Andreas, Stachon, Peter
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2019
Assuntos:
Original Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7042185/
https://ncbi.nlm.nih.gov/pubmed/31325043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00392-019-01511-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados